← Open Payments lookup

KARL KRUSZYNSKI: Open Payments

NPI 1992810220 · KINGSTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,626 in 65 payments from 15 companies in 2025. Trend: 2023 $1,619 · 2024 $2,125 · 2025 $1,626

Food & beverage: $1,337Education: $289
CompanyPaymentsAmount
Janssen Biotech, Inc.8$385
ABBVIE INC.15$325
Lilly USA, LLC9$143
Regeneron Healthcare Solutions, Inc.4$136
Novartis Pharmaceuticals Corporation6$121
Incyte Corporation5$117
UCB, Inc.3$110
Galderma Laboratories, L.P.3$68
GENZYME CORPORATION2$48
E.R. Squibb & Sons, L.L.C.3$43

Products named: TREMFYA, DUPIXENT, SKYRIZI, TALTZ, RINVOQ, OPZELURA, Bimzelx, COSENTYX.

Industry payments across NY — which companies pay providers there.